These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7960695)

  • 1. Cancer and hypocholesterolemia.
    Markel A; Brook GJ
    Isr J Med Sci; 1994 Oct; 30(10):787-93. PubMed ID: 7960695
    [No Abstract]   [Full Text] [Related]  

  • 2. The statin-low cholesterol-cancer conundrum.
    Ravnskov U; McCully KS; Rosch PJ
    QJM; 2012 Apr; 105(4):383-8. PubMed ID: 22156736
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypocholesterolemia and cancer].
    Chen ZM; Li WX
    Zhonghua Yi Xue Za Zhi; 1986 Oct; 66(10):631-3. PubMed ID: 3098371
    [No Abstract]   [Full Text] [Related]  

  • 4. Statin treatment does not cause cancer.
    Steinberg D
    J Am Coll Cardiol; 2008 Sep; 52(14):1148-9. PubMed ID: 18804741
    [No Abstract]   [Full Text] [Related]  

  • 5. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low LDL-C levels and cancer reassuring but still not definitive.
    Ben-Yehuda O; DeMaria AN
    J Am Coll Cardiol; 2008 Sep; 52(14):1150-1. PubMed ID: 18804742
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Chikamori T; Sugimoto K; Hamada T; Kitaoka H; Furuno T; Seo H; Doi Y
    J Cardiol; 2000 Feb; 35(2):95-101. PubMed ID: 10713930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemia.
    Hilleman DE; Phillips JO; Mohiuddin SM; Ryschon KL; Pedersen CA
    Clin Ther; 1999 Mar; 21(3):536-62. PubMed ID: 10321422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages.
    Fuhrman B; Elis A; Aviram M
    Biochem Biophys Res Commun; 1997 Apr; 233(3):658-62. PubMed ID: 9168909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
    Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
    J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HMG-CoA reductase inhibitors: a brief review of their pharmacological properties and clinical efficacy in cardiovascular disease].
    da Silva PM
    Rev Port Cardiol; 1999 Jan; 18(1):65-76. PubMed ID: 10091528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and cancer development.
    Duncan RE; El-Sohemy A; Archer MC
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1897-8. PubMed ID: 16103434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG CoA reductase inhibitors for treatment of hyperlipidemia.
    Kantner TR
    Am Fam Physician; 1993 May; 47(7):1623-7. PubMed ID: 8503348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental model of escape phenomenon in hamsters and the effectiveness of YM-53601 in the model.
    Ugawa T; Kakuta H; Moritani H; Shikama H
    Br J Pharmacol; 2002 Mar; 135(6):1572-8. PubMed ID: 11906972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A downside of statins?
    Healy B
    US News World Rep; 2007 Aug; 143(4):62. PubMed ID: 17853582
    [No Abstract]   [Full Text] [Related]  

  • 17. The expanding role of the HMG-CoA reductase inhibitor, the most widely prescribed drug in the world.
    Futterman LG; Lemberg L
    Am J Crit Care; 2005 Nov; 14(6):555-8. PubMed ID: 16249593
    [No Abstract]   [Full Text] [Related]  

  • 18. [Renewed proof: inhibition of cholesterol biosynthesis by dried extract of artichoke leaves].
    Forsch Komplementarmed; 1999 Jun; 6(3):168-9. PubMed ID: 10490343
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.
    de Lau LM; Stricker BH; Breteler MM
    Mov Disord; 2007 Oct; 22(13):1985. PubMed ID: 17557354
    [No Abstract]   [Full Text] [Related]  

  • 20. Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors.
    Pfefferkorn JA; Choi C; Song Y; Trivedi BK; Larsen SD; Askew V; Dillon L; Hanselman JC; Lin Z; Lu G; Robertson A; Sekerke C; Auerbach B; Pavlovsky A; Harris MS; Bainbridge G; Caspers N
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4531-7. PubMed ID: 17574411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.